NGAL in AKI and cirrhosis-Ready for prime time? von Allegretti, Andrew S

Volltext

Clinical Application of Kidney Biomarkers in Cirrhosis von Allegretti, Andrew S., Solà, Elsa, Ginès, Pere

Volltext

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures von Allegretti, Jessica R., Allegretti, Andrew S., Phelps, Emmalee, Xu, Huiping, Fischer, Monika, Kassam, Zain

Volltext

Letter: real‐world use of terlipressin in patients with the hepatorenal syndrome—authors' reply von Allegretti, Andrew S., Jamil, Khurram, Moore, Kevin

Volltext

Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY von Allegretti, Andrew S

Volltext

Letter: HRS‐AKI—a frequent misdiagnosis in the real world setting? Authors' reply von Moore, Kevin, Jamil, Khurram, Allegretti, Andrew S.

Volltext

Editorial: treating hepatorenal syndrome—a window and the views. Authors' reply von Allegretti, Andrew S., Jamil, Khurram, Moore, Kevin

Volltext

Case 13-2024: A 27-Year-Old Man with Leg Weakness von Allegretti, Andrew S., Czawlytko, Cynthia L., Stathatos, Nikolaos, Sadow, Peter M.

Volltext

Blood Microbiome Profile in CKD : A Pilot Study von Shah, Neal B, Allegretti, Andrew S, Nigwekar, Sagar U, Kalim, Sahir, Zhao, Sophia, Lelouvier, Benjamin, Servant, Florence, Serena, Gloria, Thadhani, Ravi Ishwar, Raj, Dominic S, Fasano, Alessio

Volltext

Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement von Allegretti, Andrew S, Frenk, Nathan E, Li, Darrick K, Seethapathy, Harish, Vela Parada, Xavier F, Long, Joshua, Endres, Paul, Pratt, Daniel S, Chung, Raymond T, Ganguli, Suvranu, Irani, Zubin, Yamada, Kei

Volltext

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT von Allegretti, Andrew S, Parada, Xavier Vela, Eneanya, Nwamaka D, Gilligan, Hannah, Xu, Dihua, Zhao, Sophia, Dienstag, Jules L, Chung, Raymond T, Thadhani, Ravi I

Volltext

Terlipressin versus other vasoactive drugs for hepatorenal syndrome von Israelsen, Mads, Krag, Aleksander, Allegretti, Andrew S, Jovani, Manol, Goldin, Alison H, Winter, Rachel W, Gluud, Lise Lotte, Israelsen, Mads

Volltext

Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance von Allegretti, Andrew S., Subramanian, Ram M., Francoz, Claire, Olson, Jody C., Cárdenas, Andrés

Volltext

Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice von Battistone, Maria Agustina, Mendelsohn, Alexandra C., Spallanzani, Raul German, Allegretti, Andrew S., Liberman, Rachel N., Sesma, Juliana, Kalim, Sahir, Wall, Susan M., Bonventre, Joseph, Lazarowski, Eduardo R., Brown, Dennis, Breton, Sylvie

Volltext

Response to Weng von Allegretti, Andrew S.

Volltext

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome von Moore, Kevin, Jamil, Khurram, Verleger, Katharina, Luo, Linlin, Kebede, Nehemiah, Heisen, Marieke, Corman, Shelby, Leonardi, Roberta, Bakker, Rachel, Maï, Christine, Shamseddine, Nisreen, Huang, Xingyue, Allegretti, Andrew S.

Volltext

The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease von Tang, Mengyao, Berg, Anders, Rhee, Eugene P, Allegretti, Andrew S, Nigwekar, Sagar, Karumanchi, S Ananth, Lash, James P, Kalim, Sahir

Volltext

Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes... von Verberne, Wouter R., Das-Gupta, Zofia, Allegretti, Andrew S., Bart, Hans A.J., van Biesen, Wim, García-García, Guillermo, Gibbons, Elizabeth, Parra, Eduardo, Hemmelder, Marc H., Jager, Kitty J., Ketteler, Markus, Roberts, Charlotte, Al Rohani, Muhamed, Salt, Matthew J., Stopper, Andrea, Terkivatan, Türkan, Tuttle, Katherine R., Yang, Chih-Wei, Wheeler, David C., Bos, Willem Jan W.

Volltext

Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective von Patidar, Kavish R., Piano, Salvatore, Cullaro, Giuseppe, Belcher, Justin M., Allegretti, Andrew S.

Volltext

Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD von Allegretti, Andrew S., Zhang, Wenbin, Zhou, Wenjiong, Thurber, Tara K., Rigby, Scott P., Bowman-Stroud, Cynthia, Trescoli, Carlos, Serusclat, Pierre, Freeman, Mason W., Halvorsen, Yuan-Di C.

Volltext